Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 243.76M | 598.56M | 2.43B | 2.17B | 1.15B |
Gross Profit | -82.26M | -260.18M | 708.41M | 675.62M | 274.77M |
EBITDA | -118.22M | -321.76M | 696.61M | 632.38M | 259.93M |
Net Income | -147.80M | -344.64M | 490.50M | 324.90M | 173.69M |
Balance Sheet | |||||
Total Assets | 1.05B | 1.29B | 1.99B | 1.89B | 1.43B |
Cash, Cash Equivalents and Short-Term Investments | 400.41M | 529.62M | 1.11B | 773.55M | 259.73M |
Total Debt | 289.32M | 265.88M | 134.64M | 228.18M | 344.30M |
Total Liabilities | 427.02M | 523.23M | 764.65M | 1.08B | 911.93M |
Stockholders Equity | 618.04M | 765.84M | 1.22B | 816.21M | 524.74M |
Cash Flow | |||||
Free Cash Flow | -171.63M | -511.23M | 424.05M | 633.54M | 122.69M |
Operating Cash Flow | -81.58M | -385.65M | 434.01M | 655.81M | 129.02M |
Investing Cash Flow | -89.54M | -125.70M | -9.85M | -27.68M | -10.90M |
Financing Cash Flow | 32.87M | -732.00K | -95.52M | -110.89M | 5.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | $10.49B | 10.77 | 1.52% | 2.68% | 2.24% | -33.79% | |
43 Neutral | S$53.69M | ― | -21.30% | ― | -60.43% | 57.93% | |
― | S$41.77M | 5.85 | -17.75% | 2.73% | ― | ― | |
― | S$53.32M | 6.75 | 14.57% | 2.50% | ― | ― | |
― | S$54.32M | 134.55 | 0.37% | 3.38% | ― | ― | |
― | S$52.45M | 23.56 | 3.88% | 5.08% | ― | ― | |
― | S$33.12M | ― | -10.42% | ― | ― | ― |
Jiutian Chemical Group Limited has received a notice of arbitration from a minority shareholder of its former subsidiary, Changzhou Jiutian Xiean Chemical Co., Ltd, which is undergoing creditor’s voluntary liquidation. The arbitration, filed with the Shanghai International Arbitration Center, involves a compensation claim of RMB 2 million for alleged investment losses. The company is reviewing the claim with legal advisors and will update shareholders on any significant developments, advising caution in dealing with its securities.
Jiutian Chemical Group Limited has announced a third extension of the Long-Stop Date for its Framework Agreement and Synthetic Ammonia Project Transfer Agreement with Anyang Chemical Industry Group Co., Ltd. The extension, now set for December 31, 2025, is necessary to fulfill certain conditions precedent. The company has not reported significant developments since its last update and advises shareholders to exercise caution with their securities.
Jiutian Chemical Group Limited held its Twentieth Annual General Meeting at Voco Orchard Singapore, where the Board of Directors and key company officials were present. The meeting was chaired by Executive Director Mr. Lee Chee Seng and addressed shareholder questions regarding resolutions, with responses published on SGXNet prior to the meeting.